+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 1Day - 100Years
All Genders
Healthy Volunteers
ID00027274

Natural History Study of Cancer Risks in Inherited Bone Marrow Failure Syndromes Including Fanconi Anemia and Related Disorders

Led by National Cancer Institute (NCI) · Updated on 2026-10-29

4000

Participants Needed

2

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating cancer risks and types in people with Inherited Bone Marrow Failure Syndromes IBMFS, including Fanconi Anemia, Diamond Blackfan Anemia, and others. This study focuses on understanding how genetic changes in IBMFS contribute to cancer development and identifying additional risk factors. Families with IBMFS are also studied to explore cancer risks in carriers of these gene variants. This observational natural history study involves questionnaires, clinical evaluations, laboratory tests, medical record reviews, and cancer surveillance. Participants include patients with IBMFS, their family members, and some individuals with specific cancers but without usual risk factors. The study tracks the occurrence of cancers and markers of pre-cancerous conditions over time. Participants provide health information through interviews and clinical tests, which may include blood and tissue analyses and cancer screenings. Researchers monitor for all types of cancer and pre-malignant conditions to understand cancer risks linked to IBMFS genes. Participation may last for many years as the study follows families and individuals to gather comprehensive data on cancer development.

CONDITIONS

Brief Title

Cancer in Inherited Bone Marrow Failure Syndromes

Research Team

N

NCI Family Study Referrals

L

Lisa J McReynolds, M.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here